Background: Burnout is increasingly being recognized as a contributory factor to the erosion of a positive psychological state. Studies have examined the relationship between burnout and various inflammatory markers such as IL-1, IL-6, and TNF-alpha. Burnout is also associated with increased systemic inflammation along a continuum of symptom severity. This protocol is for a scoping review looking at the link between burnout, inflammatory markers, and cardiovascular risks or diseases. Methods: This study will be based on the preferred reporting items for systematic reviews and meta-analyses guidelines/checklists and the report of the review will be based on the same guideline. The study seeks to address the following principal questions. (i) What are the relevant inflammatory biomarkers that mediate cardiovascular risk factors in burnout? (ii) How do inflammatory biomarkers mediate cardiovascular risk factors in burnout? The outputs obtained from the literature search will be deduplicated using the Rayyan software. Results: We would create table summaries of findings to inform a narrative synthesis of the evidence from the papers included. Conclusion: The review article would help to concisely synthesize the available evidence on the relationship between burnout, inflammatory markers, and cardiovascular diseases.
2 January 2025 in International Journal of Emerging Multidisciplinaries: Biomedical and Clinical Research
Background: Nigeria has a young population, almost half less than 14 years old. Violent crimes such as kidnapping, banditry, and terrorism continue to plague threats to the young population with consequent effects on the Quality of Life. Objective: This study aims to determine the relationship between experience of terrorism and Quality of life among adolescents in Mangu Village, Plateau State. Methodology: This descriptive cross-sectional study was conducted between Dec. 2023 and January 2024, among adolescents aged 10-19 years, living in Mangu Village, Plateau State with a sample size of 200 determined using Taro Yamane formula. Data were collected through standardized semi-structured, pre-tested questionnaires covering socio-demographic information, terrorism experiences, and the quality of life of respondents. The SPSS version 20.0 was used for statistical analysis, including regression to assess the relationship between terrorism experience and the quality of life of respondents. Results: A total number of one hundred and thirty-two (66.0%) were above 16 years old, while one hundred and seven (53.5%) were females. About 92.5% have experienced terrorist attacks before, during which 24.3% felt stressed, 34.6% were sad, and 23.2% were pained. Most of the respondents (53%) were less than 1 month after the duration of the terrorist attack, and 75.7% of the respondents experienced the attacks frequently. 49% of the respondents were self-wishing for death and away from it all. A total number of 114 (57%) of respondents were of good quality of life, while 86 (43% ) were poor during the attack. Conclusion: This study found that most of the adolescents had experienced terrorist attack with a little less than half of them having poor QoL. We recommend the development of policies and programmes that will improve the quality of life of adolescents exposed to terrorism.
5 November 2024 in Journal of Case Reports in Medical Science
Fetal and neonatal alloimmune thrombocytopenia FNAIT is the leading cause of severe thrombocytopenia in the fetus and neonate leading to serious bleeding, intracranial haemorrhage and death and also intracranial haemorrhage in full-term infants. We reported a case of a 33-year-old woman who was delivered of a male neonate via Emergency lower segment Cesarean section CS on account of premature rupture of the membrane with oligo hydramnios at an estimated gestational age EGA of 29 weeks 3 days. Her blood group is O Rhesus D positive, and Genotype HbAA. No known premorbid illness. Her last confinement was of a male child delivered via CS and died within 12 hours of birth. This reported case of suspected FNAIT was a baby received alive after CS with birthweight of 1,060g and APGAR score of 7185 transiently, and was noticed to be bleeding from the mouth and anus shortly after birth. Thereafter, he had thrombocytopenia, persistent anaemia, several apneic attacks, seizures, desaturation and died after 42 hours of life despite all prompt clinical interventions. Autopsy summary includes anaemia, central cyanosis, petechial hemorrhage, diffuse alveolar damage, cerebral edema, acute tubular necrosis, small for gestational age and placental vasculopathy. Conclusion: Fetal and neonatal alloimmune thrombocytopenia is a rare disorder and yet poses a challenging diagnosis and treatment plan in resource-limited centres especially in developing countries. Although the clinical findings of the reported suspected case were not classical as previously reported by other studies, they’re pointers to our curiosity and open to further criticism.
6 October 2023 in Asian Journal of Pediatric Research
Obesity is a major risk factor for cardiovascular diseases, type 2 diabetes, and other chronic illnesses. There are approximately 21 million overweight and obese people in Nigeria over the age of 15, with corresponding age-adjusted prevalence rates of 20.3% and 11.6% respectively. It is recommended that patients with a body mass index (BMI) of at least 30kg/m2 or those with comorbidities related to obesity and a BMI of at least 27kg/m2 will benefit from weight-loss medications. Although dietary and activity changes are still essential components of weight loss strategies, medications are seen as an additional treatment when lifestyle changes are not enough to reach weight loss objectives. Typically, pharmacotherapy for obesity focuses on pathways related to energy metabolism, appetite control, and fat storage. Recently, the dual glucose-dependent insulinotropic polypeptide receptor (GIPR) and GLP-1R agonist, (Tirzepatide) has shown improved weight loss compared to selective GLP-1R agonists in patients with T2DM. Glucagon, similar in structure to GLP-1 and GIP, was incorporated into the duos to form a single chimera peptide (Retatrudide) and the trio hormones are recognized by their three separate receptors. Given the benefits of the dual GIPR and GLP-1R agonist, tirzepatide, a triple agonist retatrudide, targeting all 3 receptors, has the potential to provide a therapeutic approach with superior glycemic control and weight loss than what has been achieved with single and dual receptor agonists. This report is a literature review of existing research or reports on obesity or overweight or anti-obesity drug or weight loss drugs, aim to explore the evolution of weight-loss drugs, revolutionary novel therapies, and the need for their general acceptability in developing countries like Nigeria. Databases of PubMed, Google Scholar, and ResearchGate were searched to identify relevant articles published up to recent. The search terms were obesity OR pharmacotherapy for obesity OR weight loss drugs OR novel weight management drugs. The use of medications for the management of obesity is a subject of continuing research and clinical interest. Despite breakthrough discoveries of novel medications with minimal side effects but have limited adoption in low- and middle-income countries.
12 September 2025 in Cardiology and Angiology: An International Journal
Background: Myocardial infarction may go undetected as a catastrophic event leading to hemodynamic deterioration and sudden death. The role of cardiac makers in the prompt diagnosis of acute myocardial infarction AMI has been established especially in patient presenting with clinical features coronary artery disease, however, the use of known cardiac biomarkers in the risk assessment of MI in newly diagnosed patients with hypertension is unpopular. This study aimed to assess the risk for myocardial infarction using cardiac troponin I and Atherogenic indices in newly diagnosed drug naïve patients with hypertension. Methods: The cross-sectional descriptive study was conducted among one hundred and seventeen subjects ≥18years. Anthropometric measurements and physical examination were done. Atherogenic indices for cardiovascular risk were estimated alongside biochemical parameters including cardiac Troponin I, lipid profiles, urea/creatinine and blood glucose. Data obtained were analysed using SPSS version 26, at p <0.05. Results: Most of the respondents were within the fourth decade of life, mean age of 45.24 ± 15.89 years. There was a preponderance for female sex with a male to female ratio of 1:1.2. Commonly reported clinical symptoms were palpitations, chest pain, shoulder pain and fatigue. The prevalence of cardiac troponin I (cTnI) was 10.3%, overall dyslipidaemia prevalence 97.4%, commonest was hypertriglyceridemia, and commonest pattern was mixed dyslipidaemia 70.2%. The majority with high cTnI had high CVD risk classified with AIP and CRR1. AIP demonstrated strong positive correlations with CRR1 P<0.05. And cTnI is a strong predictor with good discrimination (AUC = 0.762) and balanced sensitivity (81.42%) and specificity (75%). Conclusion: Cardiac troponin I showed good risk assessment value. The presence of cTnI activities clearly indicates an ongoing myocadiac structural changes, demonstrating a strong predictive strength. Also, AIP was identified as most important atherogenic index in drug naïve hypertensives.